• Tue news: Merck's Keytruda stages comeback in head and neck cancer. GSK, Pfizer RSV vaccine sales fall. Astellas gene therapy bet. Extreme weather —>drug shortages. J&J discontinues bladder cancer drug. See more on our front page

PDI Dedicated

Anonymous board for PDI dedicated sales force
Replies
3
Views
1K
Anonymous
Replies
3
Views
934
Anonymous
Replies
485
Views
33K
Anonymous
Replies
15
Views
2K
Anonymous
Replies
13
Views
3K
Anonymous
Replies
1
Views
1K
Anonymous
Replies
8
Views
2K
Anonymous